跳至主要内容
临床试验/NCT03067012
NCT03067012已完成不适用

Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery (Long Limb Uncut Roux-en Y Gastrojejunostomy) for Obese Gastric Cancer

Seoul National University Bundang Hospital0 个研究点目标入组 20 人开始时间: 2015年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
micronutrients' deficiency (iron, folate, vitamin B12)

研究概览

简要总结

The metabolic effect of oncometabolic surgery (long limb Roux-en Y reconstruction) for early gastric cancer patients has been revealed in a few pilot studies. However, the nutritional safety has not been dealt with in previous literatures. This is a prospective pilot study for evaluating the nutritional safety and metabolic benefits of oncometabolic surgery for obese early gastric cancer patients.

详细描述

We performed long limb uncut Roux-en Y gastrojejunostomy (uRYGJ) in 20 patients with clinical T1N0 stage and preoperative body mass index (BMI) ≥ 32.5 kg/m2 or ≥ 27.5 kg/m2 with co-morbidities between September 2015 and July 2016.

The primary endpoint was the incidence of micronutrients' deficiency (iron, folate, vitamin B12) at postoperative 1 year and secondary endpoints were anemia incidence, BMI change and remission rates of co-morbidities.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lesion located on distal or mid stomach Lesion confined to submucosa (cT1b) : Early gastric cancer No evidence of metastatic enlarged lymph nodes Preoperative body mass index (BMI) ≥ 32.5 kg/m2 or ≥ 27.5 kg/m2 with co-morbidities

排除标准

  • Being unable to understand the risks, benefits and compliance requirements of this trial Non- Korean speaker American society of anesthesiology (ASA) class IV or higher Other malignancy within 5 years.

研究组 & 干预措施

Oncometabolic reconstruction

Experimental

Patients undergoing oncometablic surgery

干预措施: Oncometabolic reconstruction (Other)

结局指标

主要结局

micronutrients' deficiency (iron, folate, vitamin B12)

时间窗: postoperative 1-year

Iron deficiency : serum ferritin \< 20 μg/dL, Vitamin B12 deficiency : serum vitamin B12 \< 200 pg/mL,

次要结局

  • Body mass index (BMI) change(postoperative 1-year)
  • anemia incidence(postoperative 1-year)
  • Remission rates of co-morbidities(postoperative 1-year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Young Suk Park

Clinical Professor

Seoul National University Bundang Hospital

相似试验